Ionis Pharmaceuticals, Inc. (ISI)
XSTU
39.22
+0.36 (+0.93%)
Real-time Data
06:00 AM
Day's Range
38.9339.54
52 wk Range
37.7175.88
Financial Statements - ISI - Ionis Pharmaceuticals, Inc.
Revenue
943.71M▲ 33.8%
Net Income
-381.38M▲ 16.0%Net Margin -40.4%
EBITDA
-380.61M▲ 16.9%
Free Cash Flow
-325.66M▲ 40.9%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 943.71M | 705.13M | 787.64M | 587.36M | 810.45M | 729.26M |
| Cost of Goods | 15.90M | 11.21M | 9.13M | 14.11M | 10.84M | 11.94M |
| Gross Profit | 927.80M | 693.92M | 778.51M | 573.25M | 799.61M | 717.31M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -381.71M | -475.10M | -353.71M | -410.19M | -14.73M | -149.96M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 92.62M | 105.46M | 101.22M | 160.32M | -5.01M | 24.84M |
| Pre Tax Income | -379.60M | -460.06M | -333.96M | -257.98M | -29.14M | -134.55M |
| Income Tax | 1.78M | -6.17M | 32.32M | 11.73M | -551K | 345.19M |
| Net Income | -381.38M | -453.89M | -366.28M | -269.72M | -28.59M | -479.74M |
| EPS Basic | -2.38 | -3.04 | -2.56 | -1.9 | -0.2 | -3.23 |
| EPS Diluted | -2.38 | -3.04 | -2.56 | -1.9 | -0.2 | -3.23 |
| Basic Shares Outstanding | 160M | 150M | 148.82M | 147.78M | 146.74M | 145.70M |
| Diluted Shares Outstanding | 160M | 150M | 148.82M | 147.78M | 146.74M | 145.70M |
| Ebit | -295.31M | -375.71M | -258.36M | -249.86M | -24.74M | -128.35M |
| Ebitda | -380.61M | -457.84M | -322.83M | -395.36M | -9.93M | -136.19M |
| Net Income Continuous Operations | -381.38M | -453.89M | -366.28M | -269.72M | -28.59M | -479.74M |
| Minority Interests | - | - | - | 0 | 0 | 35.48M |
| Preferred Stock Dividends | - | - | - | - | - | 201K |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
